TITLE

2011 - Quadruple-drug therapy was better than triple-drug therapy for eradicating Helicobacter pylori in adults

AUTHOR(S)
Talley, Nicholas J.
PUB. DATE
June 2011
SOURCE
ACP Journal Club;6/21/2011, Vol. 154 Issue 6, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Question What are the efficacy and safety of quadruple-drug therapy compared with standard triple-drug therapy for eradicating Helicobacter pylori infection? Methods Design Randomized controlled trial. ClinicalTrials.gov NCT00669955. Allocation Concealed.* Blinding Unblinded.* Follow-up period 10 weeks. Setting 39 centers in France, Germany, Ireland, Italy, Poland, Spain, and the UK. Patients 440 patients >18 years of age (mean age 48 y, 54% men among 438 patients treated) with confirmed H. pylori infection (positive urea breath test; positive rapid urease test; and positive histology, culture, or polymerase chain reaction assay) and upper gastrointestinal (GI) symptoms. Women of child-bearing potential had to use medically acceptable contraception during and up to 30 days after the end of the study. Exclusion criteria included substantial organ impairment; severe or unstable cardiopulmonary or endocrine disease; history of upper GI tract surgery; bleeding or iron-deficiency anemia; Barrett esophagus or high-grade dysplasia; dysphagia; history of cancer; drug or alcohol misuse in the past year; past use of antibiotics for H. pylori; continuous use of antiulcer drugs, antibiotics or bismuth compounds, systemic glucocorticoids, nonsteroidal antiinflammatory drugs, or anticoagulation or platelet aggregation inhibitors other than acetylsalicylic acid >100 mg/d; and pregnancy or nursing. Intervention Quadruple therapy for 10 days (n =>218) or standard therapy for 7 days (n =>222). Quadruple therapy comprised omeprazole, 20 mg, twice daily, plus 3 capsules 4 times daily; each capsule contained a combination of bismuth subcitrate potassium, 140 mg; metronidazole, 125 mg; and tetracycline hydrochloride, 125 mg. Standard therapy comprised omeprazole, 20 mg; amoxicillin, 500 mg; and clarithromycin, 500 mg, each twice daily. Outcomes H. pylori eradication (negative urea breath tests at 6 and 10 wk) and adverse events. Patient follow-up 91% completed the study (intention-to-treat analysis). Main results Quadruple therapy was better than standard therapy for eradicating H. pylori (Table). The proportion of patients with treatment-emergent adverse events was similar in both groups (all events 47% vs 51%, P =>0.44; severe events 5% vs 7%, P =>0.36; P values calculated from data in article). Conclusion Quadruple-drug therapy was better than standard triple-drug therapy for eradicating H. pylori in adults.
ACCESSION #
65456993

 

Related Articles

  • Quadruple or Triple Therapies for Helicobacter pylori. Sadovsky, Richard // American Family Physician;3/1/2003, Vol. 67 Issue 5, p1086 

    Examines the use of quadruple or proton pump inhibitor (PPI) triple therapies for Helicobacter pylori. Treatment for Helicobacter pylori; Effects of using quadruple-drug therapy using a PPI with bismuth triple therapy; Diseases where eradication therapy is being used; Efficacy of the PPI-based,...

  • Sequential Therapy Versus Standard Triple-Drug Therapy for Helicobacter pylori Eradication.  // Einstein (16794508);Apr2009, Vol. 7 Issue 2, p77 

    The article presents a reprint of an article related to the eradication of Helicobacter pylori (H. pylori), which appeared in the journal "Annals of Internal Medicine." It focuses on a study done to find whether sequential treatment is better than standard triple-drug therapy for the eradication...

  • 10-day sequential therapy was more effective than 10-day triple-drug therapy for eradicating Helicobacter pylori infection.  // ACP Journal Club;Sept/Oct2007, Vol. 147 Issue 2, p40 

    The article reports on a study that compares the efficacy of 10-day sequential therapy and 10-day triple-drug therapy for uprooting Helicobacter pylori infection in patients with dyspepsia or peptic ulcer disease. A randomized controlled trial is designed. The subjects had dyspepsia or peptic...

  • A sequential 10-day regimen was better than standard triple therapy for eradicating Helicobacter pylori in older patients.  // ACP Journal Club;Jan/Feb2006, Vol. 144 Issue 1, p2 

    This article presents a clinical study according to which high rate of Helicobacter pylori eradication with sequential therapy helps elderly patients with peptic ulcer. In older patients with peptic ulcer, is a sequential 10-day therapy regimen better than standard 7-day triple therapy for...

  • 10 day sequential therapy was more effective than 10 day triple drug therapy for eradicating Helicobacter pylon infection.  // Evidence Based Medicine;Oct2007, Vol. 12 Issue 5, p146 

    The article presents the authors view on the study "Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized trial." He remarks that the high eradication rate achieved by sequential therapy in the subgroup with clarithromycin resistance was based...

  • Sequential Therapy versus Standard Triple-Drug Therapy for Helicobacter pylori Eradication. Vaira, Dino; Zullo, Angelo; Vakil, Nimish; Gatta, Luigi; Ricci, Chiara; Perna, Federico; Hassan, Cesare; Bernabucci, Veronica; Tampieri, Andrea; Morini, Sergio // Annals of Internal Medicine;4/17/2007, Vol. 146 Issue 8, p556 

    Background: Antimicrobial resistance has decreased eradication rates for Helicobacter pylori infection worldwide. Objective: To determine whether sequential treatment eradicates H. pylori infection better than standard triple-drug therapy for adults with dyspepsia or peptic ulcers. Design:...

  • Eradication therapies for H. pylori. WALLING, ANNE D. // American Family Physician;1/15/1999, Vol. 59 Issue 2, p470 

    Presents information on eradication therapies for Helicobacter pylori infections. Recommended regimens; Efficacy rates; Alternative therapies.

  • Association of Helicobacter pylori and Helicobacter heilmannii - Special Case Reports and Literature Review. Ojano, Sabo; Amirthanathan, Anderson; Senya, Chhin; Sovandy, Chan; Vuthy, Sam // International Journal of Biological & Medical Research;2012, Vol. 3 Issue 1, p1450 

    The prevalence of Helicobacter pylori induced gastritis is common than other species of Helicobacter. We hereby reporting two rare gastritis cases caused by in association of H. pylori and H. heilmannii for the first time in Cambodia. The patients were treated with 14 days therapy of...

  • NONULCER DYSPEPSIA: HELICOBACTOR PYLORI OR IDIOPATHY? Kozol, Robert A. // American Journal of Gastroenterology;Mar1996, Vol. 91 Issue 3, p419 

    Discusses an overview of studies on anti-Helicobacter pylori therapy in patients with functional or non ulcer dyspepsia. Advantage of the eradication of Helicobacter pylori in patients with peptic ulcer; Result of clinical trials of anti-Helicobacter pylori therapy; Strengths of the study...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics